A detailed history of Wells Fargo & Company transactions in Definitive Healthcare Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 286,379 shares of DH stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
286,379
Previous 195,291 46.64%
Holding current value
$1.23 Million
Previous $1.58 Million 0.76%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.15 - $8.02 $469,103 - $730,525
91,088 Added 46.64%
286,379 $1.56 Million
Q1 2024

May 10, 2024

BUY
$7.61 - $10.26 $58,330 - $78,642
7,665 Added 4.09%
195,291 $1.58 Million
Q4 2023

Feb 09, 2024

SELL
$5.7 - $10.21 $139,040 - $249,052
-24,393 Reduced 11.51%
187,626 $1.87 Million
Q3 2023

Nov 13, 2023

SELL
$7.77 - $12.12 $78,647 - $122,678
-10,122 Reduced 4.56%
212,019 $1.69 Million
Q2 2023

Aug 15, 2023

BUY
$9.0 - $11.86 $973,278 - $1.28 Million
108,142 Added 94.86%
222,141 $2.44 Million
Q1 2023

May 12, 2023

BUY
$9.72 - $14.01 $916,255 - $1.32 Million
94,265 Added 477.68%
113,999 $1.18 Million
Q4 2022

Feb 13, 2023

BUY
$10.14 - $17.01 $55,952 - $93,861
5,518 Added 38.82%
19,734 $216,000
Q3 2022

Nov 14, 2022

BUY
$15.54 - $29.33 $40,668 - $76,756
2,617 Added 22.56%
14,216 $220,000
Q2 2022

Aug 12, 2022

SELL
$15.42 - $26.15 $1.41 Million - $2.39 Million
-91,457 Reduced 88.74%
11,599 $266,000
Q1 2022

May 16, 2022

BUY
$18.52 - $28.15 $872,736 - $1.33 Million
47,124 Added 84.25%
103,056 $2.54 Million
Q4 2021

Feb 14, 2022

BUY
$25.53 - $45.31 $1.31 Million - $2.32 Million
51,311 Added 1110.39%
55,932 $1.53 Million
Q3 2021

Nov 15, 2021

BUY
$42.02 - $48.99 $194,174 - $226,382
4,621 New
4,621 $198,000

Others Institutions Holding DH

About Definitive Healthcare Corp.


  • Ticker DH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 100,511,000
  • Market Cap $433M
  • Description
  • Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's...
More about DH
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.